Alerts will be sent to your verified email
Verify Email
AJANTPHARM
|
Ajanta Pharma
|
Gland Pharma
|
JB Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
21.63 % | 12.02 % | 19.49 % |
|
5yr Avg Net Profit Margin
|
19.77 % | 20.79 % | 16.71 % |
|
Price to Book
|
8.08 | 3.36 | 7.86 |
|
P/E
|
32.94 | 39.97 | 39.4 |
|
5yr Avg Cash Conversion Cycle
|
-102.34 Days | 69.81 Days | 7.58 Days |
|
5yr Average Interest Coverage Ratio
|
108.5 | 183.05 | 58.81 |
|
5yr Avg ROCE
|
27.48 % | 16.55 % | 23.05 % |
|
5yr Avg Operating Profit Margin
|
27.65 % | 29.26 % | 24.73 % |
|
5 yr average Debt to Equity
|
0.0 | 0.01 | 0.07 |
|
5yr CAGR Net Profit
|
7.08 % | -6.87 % | 8.05 % |
|
5yr Average Return on Assets
|
16.51 % | 10.65 % | 12.98 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
66.26 % | 51.83 % | 47.73 % |
|
Share Pledged by Promoters
|
14.12 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.22 % | -6.04 % | -6.27 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.84 % | 15.13 % | 1.15 % |
|
Ajanta Pharma
|
Gland Pharma
|
JB Chem & Pharma
|
|---|